MDL (drug)

MDL (short for Methoxy Dihydro Lysergol) is a metabolite of the drug nicergoline.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

MDL (short for Methoxy Dihydro Lysergol) is a metabolite of the drug nicergoline. It is member of the ergoline family and is a dehydrogenated and methoxylated lysergol (a lysergol in which the double bond between carbon atoms 9 and 10 has been hydrogenated and a methoxy group is attached to the 10th carbon atom in the α-configuration).

MDL is formed as a result of the N-demethylation of the metabolite MMDL; the enzyme CYP2D6 plays a key role in this chemical reaction, and its individual functional activity determines the efficiency with which this drug is metabolised in the body.

See also

Substituted ergoline

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370679924 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001370679924 · captured 2026-08-22 · ledger · version history

Cite this page as: encyclopegia.org, “MDL (drug)”, snapshot enwiki-001370679924. https://encyclopegia.org/a/mdl-drug

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.